Page 171 - Programme book for The International Liver Congress 2015, EASL ILC 2015

YI P0295 CD4+CD25+CD127LOW REGULATORY T CELLS PLAY ePOSTERS
PREDOMINANT ANTI-TUMOR SUPPRESSIVE ROLE IN
YI P0296 HEPATITIS B VIRUS ASSOCIATED HEPATOCELLULAR
YI P0297 CARCINOMA
YI P0298 Shreya Sharma, Ritu Khosla, Paul David*, Archana Rastogi,
YI P0299 Ashish K. Vyas, Ankit Bhardwaj, Amrish Sahney, Rakhi Maiwall,
YI P0300 Gayatri Ramakrishna, Shiv K. Sarin, Nirupma Trehanpati, India
YI P0301
ENOS POLYMORPHISMS IN RELATION TO OUTCOME IN
ADVANCED HCC PATIENTS RECEIVING SORAFENIB
Andrea Caadei Gardini*, Mario Scartozzi, Luca Faloppi, Giorgia Marisi,
Paola Ulivi, Emanuela Scarpi, Giovanni Luca Frassineti, Italy

THE TRANSFORMING GROWTH FACTOR-BETA (TGF-B)
GOVERNS HUMAN LIVER TUMOR CELL PLASTICITY
Andrea Malfettone*, Joan Fernando, Petra Koudelkova, Jitka Soukupova,
Esther Bertran, Àngels Fabra, Markus Grubinger, Bhavna Rani,
Gianluigi Giannelli, Wolfgang Mikulits, Isabel Fabregat, Spain

GLUCOSE TRANSPORTER ISOFORM 1 (GLUT1)
EXPRESSION DETERMINES HEPATIC METASTASIS OF
MELANOMA CELLS
Andreas Koch*, Sven A. Lang, Peter Wild, Anja Bosserhoff,
Claus Hellerbrand, Germany

SORAFENIB EFFECT ON MITOCHONDRIAL FUNCTION
PROVIDES A TARGET FOR INCREASING HCC THERAPY
EFFICACY
Anna Tutusaus, Milica Stefanovic*, Jose C. Fernandez-Checa,
Montserrat Marí, Albert Morales, Spain

DICHOTOMY OF TRANSFORMING GROWTH FACTOR-B
SIGNALING IN HEPATOCELLULAR CARCINOMA
PROGRESSION
Christine Haider*, Markus Grubinger, Wolfgang Mikulits, Austria

TARGETING OF MIR-518D REDUCES CHEMORESISTANCE
IN HEPATOCELLULAR CARCINOMA CELL LINES
David Fernández-Ramos*, Pablo Fernández-Tussy, María Jesús Peru-
gorria, Jesús María Bañales, Oscar Briz, Elisa Herráez,
José Juan García Marín, José M. Mato, María Luz Martínez-Chantar,
Spain

Vienna, Austria • April 22–26, 2015 171